Clinical Trial

Association of TLR7 Gene rs3853839 Polymorphism With Disease Severity in Alopecia Areata: A Case-Control Study

Study acronym: TLR7-AA
Completed
View on ClinicalTrials.gov →
Summary
Alopecia areata is an autoimmune, non-scarring hair loss disorder characterized by variable clinical severity. Toll-like receptor 7 (TLR7) plays a key role in innate immune activation and autoimmune responses. The rs3853839 polymorphism of the TLR7 gene has been implicated in immune-mediated diseases. This study aims to evaluate the association between TLR7 rs3853839 polymorphism and susceptibility to alopecia areata, and to assess its correlation with disease severity measured by the Severity of Alopecia Tool (SALT) score. \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Trial Details
NCT Number NCT07454876
Lead Sponsor Benha University
Conditions Alopecia Areata, TLRs
Enrollment 120 participants
Start Date 2022-12-01
Primary Completion 2023-12-10 (estimated)
Study Completion 2023-12-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-06